The inhibition of SigmaR1 in these cell lines resulted in increased cellular death by sorafenib-induced ferroptosis both in vitro and in vivo, suggesting that SigmaR1 shields hepatocellular carcinoma cells against sorafenib-induced apoptosis [27]. This evidence concerns the gene SIGMAR1 and hepatocellular carcinoma.